A cancer-fighting therapy developed at Auckland University is to receive a funding boost from some Australian venture capitalists.
Pathway Therapeutics, a spin off from Auckland Uniservices is to get $12.5million from CM Capital Investments and GBS Venture Partners.
Professor Peter Shepherd explained.